Your Strategic Dry AMD Partner
Bringing PBM (Photobiomodulation) access for dry AMD treatment to your patients
What Drives Us
With over 200,000 new cases of advanced Age-Related Macular Degeneration (AMD) every year in America, dry AMD makes up around 90% of them. Luxera Partners is a specialized clinical services provider dedicated to expanding patient access for dry AMD treatments in ophthalmology and retina practices, aiming to reduce this number every year. As one of the leading causes of vision loss in seniors, dry AMD has a growing demand for care, driven by emerging therapies that offer meaningful improvements. The main barrier is clinical capacity, not technology.
How It Works
Our PA-Integrated Treatment Model places highly trained Physician Assistants directly into partner practices, allowing for more PBM (Photobiomodulation) treatments, more efficiently. These compliant, licensed, and certified PAs handle patient flow, education, documentation, and treatment administration. This allows practices to deliver advanced dry AMD therapies in a timely and successful manner without disrupting operations, increasing physician workload, or requiring additional staffing infrastructure.
Empowering Support
At Luxera Partners, we partner with practices and help facilitate solutions for PBM (Photobiomodulation) treatments and empower practices to offer patient access to new treatments. With us, we bring foundational models that assure compliant and revenue generating results. We believe that every organization can thrive with the right guidance and support - and we are committed to being that provider.
Our Values
Access. Treatment. Vision.
Access: Remove barriers so more patients can receive dry AMD treatment.
Outcomes: Support therapies and care pathways that help preserve and improve vision.
Efficiency: Enable practices with streamlined workflows, training, and operational support.